ELYM Eliem Therapeutics Inc

5.11

0.00 (0.00%)

Pre Market

Last Updated: 00:00:00

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Eliem Therapeutics Inc	NASDAQ:ELYM	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	5.11	4.90	5.30				0	00:00:00

Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit

11/09/2024 12:00pm

GlobeNewswire Inc.

Eliem Therapeutics (NASDAQ:ELYM)
Historical Stock Chart

From Mar 2024 to Mar 2025

Click Here for more Eliem Therapeutics Charts.

Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced today members of the management team will participate at the Stifel 2024 Virtual Immunology and Inflammation Summit being held September 17-18, 2024.

Stifel 2024 Virtual Immunology and Inflammation SummitDate: Wednesday, September 18, 2024Format: 1x1 meetings

About Eliem Therapeutics, Inc.Eliem Therapeutics is focused on developing therapeutics for autoimmune-driven inflammatory diseases, including advancing budoprutug, an anti-CD19 antibody designed for a broad range of autoimmune diseases, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia and membranous nephropathy. For more information, please visit https://eliemtx.com/.

InvestorsChris Brinzey ICR Westwickechris.brinzey@westwicke.com339-970-2843